Literature DB >> 11215543

Negative symptoms of schizophrenia and compliance with medication.

T M Tattan1, F H Creed.   

Abstract

Poor compliance with medication has been reported in up to 40 percent of outpatients with schizophrenia. This study examines the relationship between compliance with depot neuroleptic medication and severity of negative symptoms of schizophrenia. Compliance with depot neuroleptic medication during the preceding year was calculated for 64 patients with a DSM-III-R diagnosis of schizophrenia. The severity of negative symptoms was assessed using the Scale for the Assessment of Negative Symptoms (SANS). Patients who complied poorly with medication had significantly greater severity of negative symptoms of schizophrenia, especially avolition, apathy, and alogia. Duration of illness and duration of prescribed medication were independently associated with compliance, but no other features were associated in the multiple regression model. These findings suggest that negative symptoms are one of the factors of importance in determining whether a patient will attend for depot neuroleptic medication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11215543     DOI: 10.1093/oxfordjournals.schbul.a006853

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  11 in total

1.  A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.

Authors:  Mohammad Arbabi; Mohaddeseh Bagheri; Farzin Rezaei; Seyyed-Ali Ahmadi-Abhari; Mina Tabrizi; Farahnaz Khalighi-Sigaroudi; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

2.  Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder.

Authors:  Robert M Roth; Matthew A Garlinghouse; Laura A Flashman; Nancy S Koven; J Cara Pendergrass; James C Ford; Thomas W McAllister; Andrew J Saykin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-02-22       Impact factor: 2.198

3.  Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Authors:  Birgit Janssen; Wolfgang Gaebel; Martin Haerter; F Komaharadi; Birgit Lindel; Stefan Weinmann
Journal:  Psychopharmacology (Berl)       Date:  2006-05-19       Impact factor: 4.530

4.  Patients' attitudes towards generic substitution of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical pharmacy setting.

Authors:  Beatriz Roman
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

5.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

6.  Apathy and the processing of novelty in schizophrenia.

Authors:  Robert M Roth; Nancy S Koven; Jo Cara Pendergrass; Laura A Flashman; Thomas W McAllister; Andrew J Saykin
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

7.  The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Joseph Ventura; Denise Gretchen-Doorly; Gerhard S Hellemann; Elisha R Agee; Laurie R Casaus; John S Luo; Kathleen F Villa; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-08-06       Impact factor: 4.939

8.  Dysthymia and apathy: diagnosis and treatment.

Authors:  Junko Ishizaki; Masaru Mimura
Journal:  Depress Res Treat       Date:  2011-06-27

Review 9.  Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.

Authors:  Giuseppe Rossi; Sonia Frediani; Roberta Rossi; Andrea Rossi
Journal:  BMC Psychiatry       Date:  2012-08-21       Impact factor: 3.630

10.  Evaluation of nonadherence to treatment among patients with schizophrenia attending psychosocial care centers in the south region of Brazil.

Authors:  Camila Poletto Viveiros; Camila Rodrigues Tatar; Deivisson Vianna Dantas Dos Santos; Sabrina Stefanello; Renato Nisihara
Journal:  Trends Psychiatry Psychother       Date:  2020 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.